For the year ending 2025-12-31, ULBI had $2,491K increase in cash & cash equivalents over the period. $7,118K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income | -5,951 |
| Depreciation | 3,981 |
| Amortization of intangible assets | 1,518 |
| Intangible asset impairment | 12,181 |
| Amortization of financing fees | 265 |
| Debt modification expense | 0 |
| Stock-based compensation | 935 |
| Deferred income tax expense | 2,541 |
| Accounts receivable | 4,354 |
| Inventories | 2,345 |
| Prepaid expenses and other assets | -1,687 |
| Income taxes receivable and payable | -170 |
| Accounts payable and other liabilities | 5,784 |
| Net cash provided by operating activities | 10,990 |
| Purchase of electrochem | 0 |
| Purchases of property, plant and equipment | 3,872 |
| Net cash used in investing activities | -3,872 |
| Borrowings on credit facility | 0 |
| Payments on credit facilities | -4,750 |
| Payment of debt issuance costs | 24 |
| Proceeds from exercise of stock options | 98 |
| Net cash used in financing activities | -4,676 |
| Effect of exchange rate changes on cash | 49 |
| Increase (decrease) in cash | 2,491 |
| Cash - beginning of year | 6,854 |
| Cash - end of year | 9,345 |
ULTRALIFE CORP (ULBI)
ULTRALIFE CORP (ULBI)